Malik Abdul

Profile
Tenure
Mar 2025 – Present
Years in office
1.6 years
Name in Japanese
アブドゥル・マリック
Title at appointment
Representative Director, President, COO
Performance in office
Kyowa Kirin
Performance in office
FY2024FY2025Change
Revenue¥495.5billion¥496.8billion+0%
Net margin12.1%13.5%+1.4pt
MiyamotoAbdul
Revenue¥496.8 billionNet margin13.5%2020/122025/122030/12
Revenue¥496.8 billionNet margin13.5%2020/122025/122030/12
Tenure

Tenure

Background

In 1999 he handled global marketing in the diabetes field at Hoechst Marion Roussel, then moved to Novartis Pharma in 2005, Genzyme in 2007 and Vifor Pharma in 2014. He joined Kyowa Kirin in March 2018 as EVP of Kyowa Kirin International and became that company's President in April 2019. In January 2023 he moved to Managing Executive Officer in charge of overseas business, and in March 2025 he became Representative Director, President and COO.

Selection

In March 2025 he became Representative Director, President and COO, succeeding Masashi Miyamoto. His predecessor simultaneously moved to Representative Director, Chairman and CEO, creating a structure that separates the CEO and COO roles. In the fiscal year ended December 2024, before he took office, consolidated revenue rose 12% from ¥442.2 billion to ¥495.5 billion, while profit before tax fell 14% from ¥97.2 billion to ¥83.5 billion. Given his seven years in charge of overseas business, the appointment appears to have entrusted him with rolling out the company's global strategic products.

Initiatives

In the fiscal year ended December 2025, his first year, consolidated revenue was ¥496.8 billion and profit before tax ¥87.2 billion, slightly above the previous year's ¥495.5 billion and ¥83.5 billion. Net income rose from ¥59.8 billion to ¥67.0 billion. Only a year and a half has passed since he took office, and there are still few facts that can be written up as initiatives of his tenure.

Career

Career

Hoechst Marion Roussel

Date Position
Jan 1999 Global Marketing Director

Novartis Pharma

Date Position
Jan 2005 Senior Global Brand Director

Genzyme

Date Position
Dec 2007 EMEA Business Unit Head
Jan 2009 VP Commercial Operations
Jan 2011 VP Head of Global Marketing

Vifor Pharma

Date Position
Sep 2014 EVP Head of Global Marketing

Kyowa Kirin

Date Position
Mar 2018 Kyowa Kirin International EVP
Apr 2019 President, Kyowa Kirin International
Jan 2023 Managing Executive Officer
Mar 2025 Representative Director, President, COO
References 1

References (Japanese primary sources)

  • 協和キリン 有価証券報告書(役員の状況)